Cystic fibrosis patients may breathe easier, thanks to bioengineered antimicrobials

By better understanding how antimicrobials bind and thereby get inactivated in the mucus of air passages, researchers at the University of Illinois may have found a way to help cystic fibrosis patients fight off deadly infections.